Your browser doesn't support javascript.
loading
Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro.
Førde, Jan-Lukas; Herfindal, Lars; Myhr, Kjell-Morten; Torkildsen, Øivind; Mollnes, Tom Eirik; Skrede, Silje.
Afiliação
  • Førde JL; Centre for Pharmacy, Department of Clinical Science, Faculty of Medicine, University of Bergen, Jonas Lies vei 87, N-5021 Bergen, Norway; Department of Internal Medicine, Haukeland University Hospital, Haukelandsveien 22, N-5021 Bergen, Norway.
  • Herfindal L; Centre for Pharmacy, Department of Clinical Science, Faculty of Medicine, University of Bergen, Jonas Lies vei 87, N-5021 Bergen, Norway.
  • Myhr KM; Department of Clinical Medicine, University of Bergen, Jonas Lies vei 87, N-5021 Bergen, Norway; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Jonas Lies vei 71, N-5021 Bergen, Norway.
  • Torkildsen Ø; Department of Clinical Medicine, University of Bergen, Jonas Lies vei 87, N-5021 Bergen, Norway; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Jonas Lies vei 71, N-5021 Bergen, Norway.
  • Mollnes TE; Research Laboratory, Nordland Hospital Trust, Prinsensgate 164, N-8005 Bodø, Norway; Department of Immunology, Oslo University Hospital and University of Oslo, Sognsvannsveien 20, N-0327 Oslo, Norway.
  • Skrede S; Section of Clinical Pharmacology, Department of Medical Biochemistry and Pharmacology, Haukeland University Hospital, Jonas Lies vei 87, N-5021 Bergen, Norway; Department of Clinical Science, University of Bergen, Jonas Lies vei 87, N-5021 Bergen, Norway. Electronic address: silje.skrede@uib.no.
Int Immunopharmacol ; 124(Pt B): 111021, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37816262
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD20 / Anticorpos Monoclonais Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos CD20 / Anticorpos Monoclonais Idioma: En Ano de publicação: 2023 Tipo de documento: Article